Inventor · Seattle, WA, US

Mark J. GILBERT

17Patents
4h-index
41Co-inventors
56Inventor score

Filing activity: Mar 4, 2013 → Jun 22, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US11413310B2 Articles of manufacture and methods for treatment using adoptive cell therapy Human Necessities 10 Active
US9421202B2 Procaspase combination therapy for glioblastoma Human Necessities 8 Active
US9592229B2 Potent anticancer activity via dual compound activation Human Necessities 8 Active
US9399035B2 Procaspase 3 activation by combination therapy Human Necessities 6 Active
US10507219B2 Methods and compositions for dosing in adoptive cell therapy Chemistry; Metallurgy 3 Active
US11944647B2 Articles of manufacture and methods for treatment using adoptive cell therapy Human Necessities 2 Active
US11815514B2 Methods and compositions related to toxicity associated with cell therapy Chemistry; Metallurgy 2 Active
US11266739B2 Methods and compositions for adoptive cell therapy Chemistry; Metallurgy 1 Active
US10888560B2 Procaspase 3 activation by combination therapy Human Necessities 0 Active
US11633426B2 Methods and compositions for dosing in adoptive cell therapy Chemistry; Metallurgy 0 Active
US11844798B2 Procaspase combination therapy for glioblastoma Human Necessities 0 Active
US11844769B2 Use of cysteamine and derivatives thereof to suppress tumor metastases Human Necessities 0 Active
US11833147B2 Procaspase 3 activation by combination therapy Human Necessities 0 Active
US10085977B2 Procaspase 3 activation by combination therapy Human Necessities 0 Active
US10874666B2 Procaspase combination therapy for glioblastoma Human Necessities 0 Active
US12163952B2 Determining toxicity risk in CAR T-cell therapy Physics 0 Active
US10085978B2 Procaspase combination therapy for glioblastoma Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.